Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history

European Urology

Volumn 63, Issue 3, 2013, Pages 585-587

  Sun, Jielin ^a   Na, Rong ^a,b   Hsu, Fang Chi ^a   Zheng, S Lilly ^a   Wiklund, Fredrik ^c   Condreay, Lynn D ^d   Trent, Jeffery M ^e   Xu, Jianfeng ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GLAXOSMITHKLINE   (United States)

^e TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER PATIENT; CANCER RISK; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC SCORE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEREDITY; HISTOPATHOLOGY; HUMAN; INHERITANCE; LABORATORY TEST; LETTER; MEASUREMENT; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MEDICAL HISTORY TAKING; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84872918220     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.11.047     Document Type: Letter

References (8)

1. L.E. Johns, and R.S. Houlston A systematic review and meta-analysis of familial prostate cancer risk BJU Int 91 2003 789 794 (Pubitemid 36724060)
2. C.L. Goh, F.R. Schumacher, and D. Easton Genetic variants associated with predisposition to prostate cancer and potential clinical implications J Intern Med 271 2012 353 365
3. S.L. Zheng, J. Sun, and F. Wiklund Cumulative association of five genetic variants with prostate cancer N Engl J Med 358 2008 910 919 (Pubitemid 351397090)
4. J. Xu, J. Sun, and A.K. Kader Estimation of absolute risk for prostate cancer using genetic markers and family history Prostate 69 2009 1565 1572
5. M. Aly, F. Wiklund, and J. Xu Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study Eur Urol 60 2011 21 28
6. A.K. Kader, J. Sun, and B.H. Reck Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial Eur Urol 62 2012 953 961
7. J. Sun, A.K. Kader, and F.C. Hsu Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer Prostate 71 2011 421 430
8. Karlsson R, Aly M, Clements M, et al. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.07.027.